Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.80 |
| ▸ | TYMS | P04818 | 3/20 | 0.78 |
| ▸ | TK1 | P04183 | 3/20 | 0.77 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Thymidine Monophosphate SCHEMBL8139411 | 1.00 | POLB (0.80) | POLBTYMSTK1 | |
| Thymidine Monophosphate SCHEMBL21257 | 1.00 | POLB (0.80) | POLBTYMSTK1 | |
| Thymidine Monophosphate SCHEMBL29463974 | 1.00 | POLB (0.80) | POLBTYMSTK1 | |
| Thymidine Monophosphate SCHEMBL2037921 | 1.00 | POLB (0.80) | POLBTYMSTK1 | |
| Thymidine Monophosphate SCHEMBL8366987 | 1.00 | POLB (0.80) | POLBTYMSTK1 | |
| Thymidine Monophosphate SCHEMBL16280929 | 1.00 | POLB (0.80) | POLBTYMSTK1 | |
| Thymidine Monophosphate SCHEMBL16092807 | 1.00 | POLB (0.80) | POLBTYMSTK1 | |
| Thymidine Monophosphate SCHEMBL18785041 | 1.00 | POLB (0.80) | POLBTYMSTK1 | |
| Thymidine Monophosphate SCHEMBL7876022 | 1.00 | POLB (0.80) | POLBTYMSTK1 | |
| Thymidine Monophosphate SCHEMBL8886065 | 1.00 | POLB (0.80) | POLBTYMSTK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009063254-A2 | THYMIDINE KINASE ASSAY | UNIVERSITY OF ABERTAY, DUNDEE (GB) | 2009-05-22 | — | — | WO | claimed |
| EP-0891373-B1 | METHOD AND COMPOUNDS FOR INHIBITION OF RIBONUCLEASES | ENDOWMENT FOR RES IN HUMAN BIO (US) | 2003-03-12 | — | — | EP | claimed |
| US-11782006-B2 | Sensing systems | ILLUMINA, INC. (US) | 2023-10-10 | — | — | US | disclosed |
| CN-115125279-A | Recombinant microorganism and method for producing 2' -deoxycytidine | 苏州华赛生物工程技术有限公司 | 2022-09-30 | — | — | CN | disclosed |
| CN-110267974-A | Modified nanopores, compositions comprising the same, and uses thereof | 牛津纳米孔技术公司 | 2019-09-20 | — | — | CN | disclosed |
| CN-110168104-A | METHODS AND SYSTEMS FOR CHARACTERIZING ANALYTES USING NANOPORES | 牛津纳米孔技术公司 | 2019-08-23 | — | — | CN | disclosed |
| CN-110121562-A | Method of producing a composite material | 牛津纳米孔技术公司 | 2019-08-13 | — | — | CN | disclosed |
| CN-110088299-A | Nanopore-directed nucleic acid detection methods | 牛津纳米孔技术公司 | 2019-08-02 | — | — | CN | disclosed |
| US-20190233883-A1 | METHODS AND COMPOSITIONS FOR ANALYZING NUCLEIC ACID | SEQUENOM, INC. | 2019-08-01 | — | — | US | disclosed |
| CN-109312401-A | The nano-pore sequencing method of the nucleic acid of connection | 牛津纳米孔技术公司 | 2019-02-05 | — | — | CN | disclosed |
| CN-109219665-A | Method | 牛津纳米孔技术公司 | 2019-01-15 | — | — | CN | disclosed |
| CN-103038361-A | Kits and Methods | STAALHANDSKE PER | 2013-04-10 | — | — | CN | disclosed |
| US-20120077189-A1 | SCAFFOLD-BASED POLYMERASE ENZYME SUBSTRATES | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2012-03-29 | — | — | US | disclosed |
| WO-2009063254-A2 | THYMIDINE KINASE ASSAY | UNIVERSITY OF ABERTAY, DUNDEE (GB) | 2009-05-22 | — | — | WO | disclosed |
| US-20090018324-A1 | LABELED NUCLEOTIDE ANALOGS AND USES THEREFOR | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2009-01-15 | — | — | US | disclosed |
| US-7405281-B2 | Fluorescent nucleotide analogs and uses therefor | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2008-07-29 | — | — | US | disclosed |
| US-5519126-A | COMBATTING DISEASES BY BIOCHEMICL INTERVENTION AT THE RNA AND DNA LEVEL | UNIVERSITY OF VIRGINIA ALUMNI PATENTS FOUNDATION (US) | 1996-05-21 | — | — | US | disclosed |
| EP-0406309-A4 | OLIGONUCLEOTIDE N-ALKYLPHOSPHORAMIDATES | — | 1992-08-19 | — | — | EP | disclosed |
| EP-0406309-A1 | OLIGONUCLEOTIDE N-ALKYLPHOSPHORAMIDATES | THE UNIVERSITY OF VIRGINIA ALUMNI PATENTS FOUNDATION (US) | 1991-01-09 | — | — | EP | disclosed |
| WO-1989009221-A1 | OLIGONUCLEOTIDE N-ALKYLPHOSPHORAMIDATES | UNIVERSITY OF VIRGINIA ALUMNI PATENTS FOUNDATION (US) | 1989-10-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090018324-A1 | LABELED NUCLEOTIDE ANALOGS AND USES THEREFOR | POLRMT, DNTT, NUDT1 | POLB 14/4885TYMS 9/4885TK1 12/4885 |
| US-20120077189-A1 | SCAFFOLD-BASED POLYMERASE ENZYME SUBSTRATES | POLM, RNGTT, POLR1G | POLB 12/4885TYMS 39/4885TK1 69/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.